Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MT-6548 for anemia in chronic kidney disease patients on peritoneal dialysis in Japan has completed and posted efficacy and safety resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease

Drugs mentioned

• MT-6548

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Anemia; Peritoneal Dialysis Dependent Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-07-06